Company

Moonlight Ai GmbH

Moonlight AI analyzes hematology and cytology images to identify genomic biomarkers and support disease diagnosis.

About

Moonlight AI provides diagnostic software that uses artificial intelligence to analyze routine hematology and cytology images for genomic biomarkers. The platform is designed for diagnostic laboratories and works with existing imaging hardware. Founded in 2022 and based in Switzerland, the company raised USD 3.3 mn in Seed funding in May 2026, co-led by Lotus One Investment, VP Venture Partners, and Medin Fund Management Company, with participation from N & V Capital and QAI Ventures.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in